GM18487
LCL from B-Lymphocyte
Description:
YORUBA IN IBADAN, NIGERIA
|
Repository
|
NHGRI Sample Repository for Human Genetic Research
|
| Subcollection |
NHGRI Sample Repository for Human Genetic Research |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Country of Origin
|
NIGERIA
|
|
Family Member
|
3
|
|
Relation to Proband
|
father
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| Remarks |
Yoruba from Ibadan, Nigeria; all four grandparents are Yoruba |
| Cherlin T, Magee R, Jing Y, Pliatsika V, Loher P, Rigoutsos I, Ribosomal RNA fragmentation into short RNAs (rRFs) is modulated in a sex- and population of origin-specific manner BMC biology18:38 2019 |
| PubMed ID: 32279660 |
| |
| Paganini J, Abi-Rached L, Gouret P, Pontarotti P, Chiaroni J, Di Cristofaro J, HLAIb worldwide genetic diversity: New HLA-H alleles and haplotype structure description Molecular immunology112:40-50 2019 |
| PubMed ID: 31078115 |
| |
| Lee YQ, Storry JR, Karamatic Crew V, Halverson GR, Thornton N, Olsson ML, A large deletion spanning XG and GYG2 constitutes a genetic basis of the Xg Transfusion59:1843-1849 2018 |
| PubMed ID: 30938838 |
| |
| Londin ER, Keller MA, Maista C, Smith G, Mamounas LA, Zhang R, Madore SJ, Gwinn K, Corriveau RA.
, CoAIMs: A Cost-Effective Panel of Ancestry Informative Markers for Determining Continental Origins.
Plos One5(10):e13443 2010 |
| PubMed ID: 20976178 |
| Split Ratio |
1:5 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|